510(k) device
MOLTENO3
Iop, Inc. · Implant, Eye Valve (KYF, Class II) · First FDA decision Sep 27, 2006, newest Sep 27, 2006Glaucoma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "MOLTENO3"
MAUDE reports
0
Brand "MOLTENO3", since 2015
PubMed studies
6
Mentioning "MOLTENO3"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing MOLTENO3
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "MOLTENO3", any status and sponsor, newest update first.
No registered device study names "MOLTENO3".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "MOLTENO3", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code KYF
3,772 reports: 1,109 malfunction, 2,659 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "MOLTENO3"[tiab]. The summary above synthesizes these.
- Molteno3 implantation as primary glaucoma surgery.
Välimäki JO, Ylilehto AP · J Ophthalmol · 2014
- Intermediate-term and long-term outcome of piggyback drainage: connecting glaucoma drainage device to a device in-situ for improved intraocular pressure control.
Dervan E, Lee E, Giubilato A, et al. · Clin Exp Ophthalmol · 2017
- Effect of glaucoma drainage implant surgery on corneal topography: a prospective study.
Koivusalo R, Välimäki J · Acta Ophthalmol · 2020
- Comparative Outcomes of the Molteno3 and Baerveldt Glaucoma Implants.
Dixon MW, Moulin TA, Margolis MS, et al. · Ophthalmol Glaucoma · 2020Comparative Study, Multicenter Study
- Otago glaucoma surgery outcome study: comparative results for the 175-mm2 Molteno3 and double-plate molteno implants.
Thompson AM, Molteno AC, Bevin TH, et al. · JAMA Ophthalmol · 2013Comparative Study, Research Support, Non-U.S. Gov't
- Surgical management of glaucoma with Molteno3 implant.
Välimäki J · J Glaucoma · 2012Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code KYF.
- Ahmed® Glaucoma Valve Model FP8New World Medical, Inc. · 510(k) 2023
- iStent infinite Trabecular Micro-Bypass System, Model iS3Glaukos Corporation · 510(k) 2022
- AHMED ClearPath Glaucoma Drainage DeviceNew World Medical, Inc. · 510(k) 2019
- XEN Glaucoma Treatment SystemAllergan, Inc. · 510(k) 2016
- Molteno3 Glaucoma ImplantInnovative Ophthalmic Products, Inc. (Iop) · 510(k) 2015
- Express Mini Glaucoma ShuntOptonol, Ltd. · 510(k) 2003
- Ex-Press Minature Glaucoma Implant, Models R-20, R-30, R-50, Sts VersionsOptonol, Ltd. · 510(k) 2002
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.